Treatment of maladaptive aggression in youth: CERT guidelines I. Engagement, assessment, and management.
OBJECTIVE
To develop guidelines for management and treatment of maladaptive aggression in the areas of family engagement, assessment and diagnosis, and initial management, appropriate for use by primary care clinicians and mental health providers. Maladaptive aggression in youth is increasingly treated with psychotropic medications, particularly second-generation antipsychotic agents. Multiple treatment modalities are available, but guidance for clinicians' assessment and treatment strategies has been inadequately developed. To address this need, the Center for Education and Research on Mental Health Therapeutics and the REACH Institute convened a steering group of national experts to develop evidence-based treatment recommendations for maladaptive aggression in youth.


METHODS
Evidence was assembled and evaluated in a multistep process that included a systematic review of published literature; a survey of experts on recommended treatment practices; a consensus conference that brought together clinical experts along with researchers, policy makers, and family advocates; and subsequent review and discussion by the steering committee of successive drafts of the recommendations. The Center for Education and Research on Mental Health Therapeutics Treatment of Maladaptive Aggression in Youth (T-MAY) guidelines reflect a synthesis of the available evidence, based on this multistep process.


RESULTS
The current article describes 9 recommendations for family engagement, assessment, and diagnosis as key prerequisites for treatment selection and initiation.


CONCLUSIONS
Recognizing the family and social context in which aggressive symptoms arise, and understanding the underlying psychiatric conditions that may be associated with aggression, are essential to treatment planning.
Department of Psychiatry, University of California, Davis, Davis, California, USA.
Penelope
P
Knapp
Alanna
A
Chait
Elizabeth
E
Pappadopulos
Stephen
S
Crystal
Peter S
PS
Jensen
D000293:Adolescent; D000374:Aggression / Q000187:drug effects* / Q000523:psychology*; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D003245:Consensus Statements as Topic; D019468:Disease Management; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D020380:Needs Assessment / Q000592:standards*; D017410:Practice Guidelines as Topic / Q000592:standards*; D011613:Psychotherapy / Q000592:standards; D016896:Treatment Outcome
D014150:Antipsychotic Agents